A commercial cut-flower developer has applied for a licence to conduct open field trials for genetically modified Gypsophila flowers, targeting the American market.
In the request to the National Biosafety Authority (NBA), Imaginature Ltd said they had improved the GM Gypsophila variety, enabling it to produce many colours that made it attractive and lucrative.
“We added a few genetic elements responsible for new colour range — from dark purple to red, to light pink — in flowers from a model plant called Arapidopsis,” said the notice to NBA.
To read the rest of the story, please go to: Daily Nation
